Skip to main content
Two doctors in operating room

Deeply committed to aortic treatment

In the constant pursuit to improve outcomes, we join in service with physicians to engineer powerful products and form empowering partnerships. 

Deep commitment Continual pursuit Beyond products

Solving unmet needs through innovation

Thumbnail of video

Addressing unmet needs in EVAR


Watch Now

The only AAA device that is infrarenal by design, intended to help mitigate the risks associated with suprarenal fixation devices.

Download flyer

“Stent grafts with active fixation below the renal arteries as well as oversizing by less than 10% seem to have the least effect on aortic neck degeneration over time…”

Impact to TEVAR approach

Evolving TEVAR:
Vascular Surgeon shares his experience with TEVAR device

Preservation Matters ALWAYS

Preservation matters: Introduced the first and only FDA approved iliac branch solution


Why and when to preserve

The continual pursuit to improve outcomes

Thumbnail for Aortic Portfolio Timeline Animation

Continued Aortic Innovation


View video

We have multiple clinical and investigational trials in process, supporting a robust aortic pipeline.

Doctors having conversation in hallway

Thoracoabdominal Breakthrough Device designation


View Press Release


Photo of Thoracic Endoprosthesis in a white background

FDA Approval: first flexible, off-the-shelf single-branch thoracic endoprosthesis for patients requiring zone 2 treatment


View Press Release

Our commitment goes beyond products to build partnerships that empower

Together - Video Thumbnail

Our commitment to lifelong innovation 

View video

  1. Kay B.  Active stent-graft fixation below the renal arteries may have the least effect on aortic neck degeneration, study finds.  Vascular Specialist -Society for Vascular Surgery (SVS) website.  Posted November 17, 2020.  Accessed December 2, 2020.

* Three year follow-up of U.S. IDE Clinical Trial for all patients from primary enrollment (n = 63)